|
Cell cycle control of chromosomal replication
|
6.85E+00
|
PI3K/AKT signaling
|
5.91E+00
|
|
Granzyme A signaling*
|
6.27E+00
|
Hepatic fibrosis/hepatic stellate cell activation*
|
4.59E+00
|
|
RAN signaling
|
3.37E+00
|
NRF2-mediated oxidative stress response
|
4.11E+00
|
|
Polyamine regulation in colon cancer
|
3.03E+00
|
Glucocorticoid receptor signaling
|
4.07E+00
|
|
Role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis*
|
2.79E+00
|
Aryl hydrocarbon receptor signaling
|
3.89E+00
|
|
Airway pathology in chronic obstructive pulmonary disease
|
2.68E+00
|
IGF-1 signaling
|
3.82E+00
|
|
IL-17A signaling in fibroblasts*
|
2.44E+00
|
p53 signaling
|
3.79E+00
|
|
Hepatic fibrosis/hepatic stellate cell activation*
|
2.10E+00
|
Granzyme A signaling*
|
3.30E+00
|
|
Bladder cancer signaling*
|
2.09E+00
|
Cell cycle regulation by BTG family proteins
|
3.19E+00
|
|
Mismatch repair in eukaryotes
|
2.06E+00
|
Aldosterone signaling in epithelial cells
|
2.95E+00
|
|
Putrescine degradation III
|
2.01E+00
|
MIF regulation of innate immunity
|
2.87E+00
|
| | |
CDK5 signaling
|
2.70E+00
|
| | |
Wnt/b-catenin signaling
|
2.60E+00
|
| | |
Role of macrophages, fibroblasts and endothelial cells in Rrheumatoid arthritis*
|
2.42E+00
|
| | |
HGF signaling
|
2.38E+00
|
| | |
MIF-mediated glucocorticoid regulation
|
2.38E+00
|
| | |
Estrogen receptor signaling
|
2.37E+00
|
| | |
Role of IL-17A in arthritis
|
2.34E+00
|
| | |
VDR/RXR activation
|
2.31E+00
|
| | |
Role of CHK proteins in cell cycle checkpoint control
|
2.30E+00
|
| | |
IL-17A signaling in fibroblasts*
|
2.28E+00
|
| | |
Stearate biosynthesis I (animals)
|
2.28E+00
|
| | |
Superoxide radicals degradation
|
2.24E+00
|
| | |
Apoptosis signaling
|
2.06E+00
|
| | |
CD40 signaling
|
2.06E+00
|
| | |
Bladder cancer signaling*
|
2.03E+00
|
| | |
Melanoma signaling
|
2.00E+00
|
